2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
379
Neoplasms
336
Carcinoma, Non-Small-Cell Lung
297
Prostatic Neoplasms
250
Colorectal Neoplasms
223
Lung Neoplasms
195
Multiple Myeloma
155
Ovarian Neoplasms
142
Pancreatic Neoplasms
140
Neoplasm Metastasis
132
Leukemia, Myeloid, Acute
129
Melanoma
112
Squamous Cell Carcinoma of Head and Neck
96
Lymphoma
89
Carcinoma, Renal Cell
89
Stomach Neoplasms
87
Recurrence
87
Lymphoma, Non-Hodgkin
86
Endometrial Neoplasms
85
Brain Neoplasms
83
Carcinoma, Hepatocellular
82
Precursor Cell Lymphoblastic Leukemia-Lymphoma
81
Head and Neck Neoplasms
73
Glioma
73
Glioblastoma
73
Uterine Cervical Neoplasms
71
Sarcoma
69
Urinary Bladder Neoplasms
67
Hematologic Neoplasms
66
Leukemia, Lymphocytic, Chronic, B-Cell
65
Interventions
ribociclib
1
palbociclib
1
capivasertib
1
abemaciclib
1
Fulvestrant
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Locally Advanced (Inoperable) or Metastatic Breast Cancer
×
30 days
×
Clear all
NCT04862663
2026-05-27
CAPItello-292
AstraZeneca
Phase 3
Recruiting
895 enrolled